Breast Cancer Disparities Through the Lens of the COVID-19 Pandemic

Lisa Newman; Laura Fejerman; Tuya Pal; Eralda Mema; Geraldine McGinty; Alex Cheng; Mia Levy; Adeyiza Momoh; Melissa Troester; Bryan Schneider; Lorna McNeil; Melissa Davis; Kemi Babagbemi; Kelly Hunt

doi:10.1007/s12609-021-00419-x

Breast Cancer Disparities Through the Lens of the COVID-19 Pandemic

Lisa Newman, Laura Fejerman, Tuya Pal, Eralda Mema, Geraldine McGinty, Alex Cheng, Mia Levy, Adeyiza Momoh, Melissa Troester, Bryan Schneider, Lorna McNeil, Melissa Davis, Kemi Babagbemi, Kelly Hunt

Breast Surgical Oncology

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Abstract

Purpose of Review: The emergency medicine and critical care needs of the COVID-19 pandemic forced a sudden and dramatic disruption of cancer screening and treatment programs in the USA during the winter and spring of 2020. This review commentary addresses the impact of the pandemic on racial/ethnic minorities such as African Americans and Hispanic-Latina Americans, with a focus on factors related to breast cancer. Recent Findings: African Americans and Hispanic-Latina Americans experienced disproportionately higher morbidity and mortality from COVID-19; many of the same socioeconomic and tumor biology/genetic factors that explain breast cancer disparities are likely to account for COVID-19 outcome disparities. Summary: The breast cancer clinical and research community should partner with public health experts to ensure participation of diverse patients in COVID-19 treatment trials and vaccine programs and to overcome COVID-19-related breast health management delays that are likely to have been magnified among African Americans and Hispanic-Latina Americans.

Original language	English (US)
Pages (from-to)	110-112
Number of pages	3
Journal	Current Breast Cancer Reports
Volume	13
Issue number	3
DOIs	https://doi.org/10.1007/s12609-021-00419-x
State	Published - Sep 2021

Keywords

African Americans
Breast cancer
COVID-19
Clinical research
Disparities
Hispanic/Latina Americans

ASJC Scopus subject areas

Oncology

Access to Document

10.1007/s12609-021-00419-x

Cite this

@article{bd244e141acc4ba5bd82a900ce285254,

title = "Breast Cancer Disparities Through the Lens of the COVID-19 Pandemic",

abstract = "Purpose of Review: The emergency medicine and critical care needs of the COVID-19 pandemic forced a sudden and dramatic disruption of cancer screening and treatment programs in the USA during the winter and spring of 2020. This review commentary addresses the impact of the pandemic on racial/ethnic minorities such as African Americans and Hispanic-Latina Americans, with a focus on factors related to breast cancer. Recent Findings: African Americans and Hispanic-Latina Americans experienced disproportionately higher morbidity and mortality from COVID-19; many of the same socioeconomic and tumor biology/genetic factors that explain breast cancer disparities are likely to account for COVID-19 outcome disparities. Summary: The breast cancer clinical and research community should partner with public health experts to ensure participation of diverse patients in COVID-19 treatment trials and vaccine programs and to overcome COVID-19-related breast health management delays that are likely to have been magnified among African Americans and Hispanic-Latina Americans.",

keywords = "African Americans, Breast cancer, COVID-19, Clinical research, Disparities, Hispanic/Latina Americans",

author = "Lisa Newman and Laura Fejerman and Tuya Pal and Eralda Mema and Geraldine McGinty and Alex Cheng and Mia Levy and Adeyiza Momoh and Melissa Troester and Bryan Schneider and Lorna McNeil and Melissa Davis and Kemi Babagbemi and Kelly Hunt",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2021",

month = sep,

doi = "10.1007/s12609-021-00419-x",

language = "English (US)",

volume = "13",

pages = "110--112",

journal = "Current Breast Cancer Reports",

issn = "1943-4588",

publisher = "Current Science, Inc.",

number = "3",

}

TY - JOUR

T1 - Breast Cancer Disparities Through the Lens of the COVID-19 Pandemic

AU - Newman, Lisa

AU - Fejerman, Laura

AU - Pal, Tuya

AU - Mema, Eralda

AU - McGinty, Geraldine

AU - Cheng, Alex

AU - Levy, Mia

AU - Momoh, Adeyiza

AU - Troester, Melissa

AU - Schneider, Bryan

AU - McNeil, Lorna

AU - Davis, Melissa

AU - Babagbemi, Kemi

AU - Hunt, Kelly

PY - 2021/9

Y1 - 2021/9

N2 - Purpose of Review: The emergency medicine and critical care needs of the COVID-19 pandemic forced a sudden and dramatic disruption of cancer screening and treatment programs in the USA during the winter and spring of 2020. This review commentary addresses the impact of the pandemic on racial/ethnic minorities such as African Americans and Hispanic-Latina Americans, with a focus on factors related to breast cancer. Recent Findings: African Americans and Hispanic-Latina Americans experienced disproportionately higher morbidity and mortality from COVID-19; many of the same socioeconomic and tumor biology/genetic factors that explain breast cancer disparities are likely to account for COVID-19 outcome disparities. Summary: The breast cancer clinical and research community should partner with public health experts to ensure participation of diverse patients in COVID-19 treatment trials and vaccine programs and to overcome COVID-19-related breast health management delays that are likely to have been magnified among African Americans and Hispanic-Latina Americans.

AB - Purpose of Review: The emergency medicine and critical care needs of the COVID-19 pandemic forced a sudden and dramatic disruption of cancer screening and treatment programs in the USA during the winter and spring of 2020. This review commentary addresses the impact of the pandemic on racial/ethnic minorities such as African Americans and Hispanic-Latina Americans, with a focus on factors related to breast cancer. Recent Findings: African Americans and Hispanic-Latina Americans experienced disproportionately higher morbidity and mortality from COVID-19; many of the same socioeconomic and tumor biology/genetic factors that explain breast cancer disparities are likely to account for COVID-19 outcome disparities. Summary: The breast cancer clinical and research community should partner with public health experts to ensure participation of diverse patients in COVID-19 treatment trials and vaccine programs and to overcome COVID-19-related breast health management delays that are likely to have been magnified among African Americans and Hispanic-Latina Americans.

KW - African Americans

KW - Breast cancer

KW - COVID-19

KW - Clinical research

KW - Disparities

KW - Hispanic/Latina Americans

UR - http://www.scopus.com/inward/record.url?scp=85112669770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85112669770&partnerID=8YFLogxK

U2 - 10.1007/s12609-021-00419-x

DO - 10.1007/s12609-021-00419-x

M3 - Review article

C2 - 34394841

AN - SCOPUS:85112669770

SN - 1943-4588

VL - 13

SP - 110

EP - 112

JO - Current Breast Cancer Reports

JF - Current Breast Cancer Reports

IS - 3

ER -

Breast Cancer Disparities Through the Lens of the COVID-19 Pandemic

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this